SCHEMBL3727633

SCHEMBL3727633

COc1ccc(CCC(=O)Nc2cc(Cl)nn3c(C(=O)Nc4ccncc4F)cnc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOD2 Q9HC29 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ GAA P10253 1/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ P2RX7 Q99572 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CHEK1 O14757 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ TRPV1 Q8NER1 1/20 0.39
▸ ALPL P05186 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3722285 0.89 PI4KB (0.42) NOD2RAB9AGAAKMT2AALDH1A1
SCHEMBL3721792 0.82 NOD2 (0.39) NOD2RAB9AMEN1KMT2AALDH1A1
SCHEMBL3719962 0.80 NOD2 (0.37) NOD2HDAC1ROCK2TRPV1
SCHEMBL3721919 0.80 TYK2 (0.41) RAB9AKMT2AROCK2SMN1; SMN2
SCHEMBL3720248 0.79 NOD2 (0.36) NOD2RAB9AMEN1KMT2AALDH1A1
SCHEMBL3663899 0.78 MCL1 (0.38) RAB9AMEN1KMT2AROCK2SMN1; SMN2
SCHEMBL3721115 0.76 GAA (0.38) RAB9AGAAMEN1KMT2AHPGD
SCHEMBL13745245 0.76 RAB9A (0.36) RAB9AGAAHDAC1ROCK2SMN1; SMN2
SCHEMBL13745774 0.76 HDAC3 (0.40) HDAC1
SCHEMBL3729986 0.76 TYK2 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2240488-A1 SUBSTITUTED IMIDAZOPYRIDAZINES USEFUL AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2010-10-20 — — EP disclosed
WO-2009100375-A1 SUBSTITUTED IMIDAZOPYRIDAZINES USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-13 — — WO disclosed
Send feedback